Skip to main content
Download PDF

Proteomic analysis of exosome-like vesicles from Fasciola gigantica adult worm provides support for new vaccine targets against fascioliasis

Parasites & Vectors volume 16, Article number: 62 (2023) Cite this article

Abstract

Background

Extracellular vesicles (EVs) released by helminths play an important role in parasite-host communication. However, little is known about the characteristics and contents of the EVs of Fasciola gigantica, a parasitic flatworm that causes tropical fascioliasis. A better understanding of EVs released by F. gigantica will help elucidate the mechanism of F. gigantica-host interaction and facilitate the search for new vaccine candidates for the control and treatment of fascioliasis.

Methods

Two different populations of EVs (15k EVs and 100k EVs) were purified from adult F. gigantica culture media by ultracentrifugation. The morphology and size of the purified EVs were determined by transmission electron microscopy (TEM) and by the Zetasizer Nano ZSP high performance particle characterization system. With the aim of identifying diagnostic markers or potential vaccine candidates, proteins within the isolated 100k EVs were analyzed using mass spectrometry-based proteomics (LC–MS/MS). Mice were then vaccinated with excretory/secretory products (ESPs; depleted of EVs), 15k EVs, 100k EVs and recombinant F. gigantica heat shock protein 70 (rFg-HSP70) combined with alum adjuvant followed by challenge infection with F. gigantica metacercariae. Fluke recovery and antibody levels were used as measures of vaccine protection.

Results

TEM analysis and nanoparticle tracking analysis indicated the successful isolation of two subpopulations of EVs (15k EVs and 100k EVs) from adult F. gigantica culture supernatants using differential centrifugation. A total of 755 proteins were identified in the 100k EVs. Exosome biogenesis or vesicle trafficking proteins, ESCRT (endosomal sorting complex required for transport) pathway proteins and exosome markers, heat shock proteins and 14-3-3 proteins were identified in the 100k EVs. These results indicate that the isolated 100k EVs were exosome-like vesicles. The functions of the identified proteins may be associated with immune regulation, immune evasion and virulence. Mice immunized with F. gigantica ESPs, 15k EVs, 100k EVs and rFg-HSP70 exhibited a reduction in fluke burden of 67.90%, 60.38%, 37.73% and 56.6%, respectively, compared with the adjuvant control group. The vaccination of mice with F. gigantica 100k EVs, 15k EVs, ESP and rFg-HSP70 induced significant production of specific immunoglobulins in sera, namely IgG, IgG1 and IgG2a.

Conclusion

The results of this study suggest that proteins within the exosome-like vesicles of F. gigantica have immunomodulatory, immune evasion and virulence functions. This knowledge may lead to new strategies for immunotherapy, vaccination and the diagnosis of fascioliasis.

Graphical Abstract

Background

The digenetic trematode, Fasciola gigantica, is an important food-borne zoonotic parasite with a worldwide distribution. Infection with this parasitic flatworm can cause lack of appetite, diarrhea, liver damage, anemia, reduced weight gain and reduced milk production [1]. These symptoms result in substantial economic losses, especially in developing countries, and threaten human health [2]. Fasciola gigantica has developed adaptations to establish chronic infections through the suppression of host immunity [3]. Specifically, F. gigantica infections generally induce a non-protective T helper 2/regulatory T cells (Th2/Treg) immune response and suppression of the protection provided by T helper 1 (Th1) immune responses. This response could be initiated by the release of excretory/secretory products (ESPs) [4]. The ESPs released by F. gigantica can directly regulate the differentiation of macrophages, dendritic cells (DCs) and T cells, and they have a modulating effect on DCs, thereby promoting downstream Th2/Treg responses [5, 6]. Fasciola gigantica ESPs also induce macrophages toward an alternatively activated macrophage (M2 cells) phenotype, which promotes Th2/Treg responses [7, 8].

Helminth-derived extracellular vesicles (EVs) play an essential role in parasite-host communication by transferring parasite material to the host [9]. They can be released by the gastrointestinal tract or protonephridial system of the parasite or shed directly from the parasite’s tegument and converged into ESPs [10, 11]. EVs are small membrane-enclosed nanoparticles that are released by many organisms, including parasitic helminths and their hosts. They contain different proteins, lipids, messenger RNAs and non-coding RNAs [12, 13]. EVs released by a broad spectrum of helminths (e.g., Fasciola hepatica [14], Opisthorchis viverrini [15], Heligmosomoides polygyrus [16], Schistosoma japonicum [17], Echinococcus multilocularis [18] and Echinococcus granulosus [19]) can modulate the host immune response or transportation of virulence factors [20]. For example, EVs isolated from the ESPs of H. polygyrus can be assimilated by macrophages and inhibit macrophage activation through downregulation of pro-inflammatory tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) [21]. Opisthorchis viverrini has a strong association with cholangiocarcinoma, and the internalization of O. viverrini EVs by cholangiocytes promotes cell proliferation, IL-6 secretion and induction of protein expression associated with cancer [15]. EVs released by S. japonicum can be taken up by immune cells (including macrophages) and transferred as microRNA cargo into recipient cells for the suppression of TNF-α production [17]. Echinococcus multilocularis EVs can inhibit nitric oxide (NO) and pro-inflammatory cytokines produced by activated RAW264.7 macrophages [18]. EVs isolated from E. granulosus protoscoleces and metacestodes from the supernatants of cultures suppressed the maturation of DCs and the antigen presentation pathway, which may play a role in immunomodulation [19].

The molecular composition of EVs secreted by F. gigantica may be involved in immune regulation of the host and F. gigantica–host communication. For a better understanding of the relationship between F. gigantica and its host, we used differential ultracentrifugation to isolate two types of EVs (15k EVs and 100k EVs) from the supernatants of adult F. gigantica cultures. We also used mass spectrometry (MS)-based proteomics (liquid chromatography [LC]–MS/MS) analyses of proteins within the isolated 100k EVs to demonstrate that the 100k EVs contained several proteins related to immune regulation, immune evasion and virulence. These proteins are possible diagnostic markers and vaccine candidates. We also show that F. gigantica secretes ESPs, 15k EVs and 100k EVs that induce protective immunity to infection.

Methods

Animals

Female ICR mice aged 5–7 weeks were purchased from Hunan SJT Laboratory Animal Co., Ltd. (Changshang, China) and maintained under pathogen-free conditions in the laboratory animal room of the Parasitology Unit, Guangxi University, China.

Preparation of ESPs

Adult F. gigantica parasites were obtained from the gallbladders of freshly killed swamp buffaloes at local abattoirs. Adult parasites were washed three times with phosphate-buffered saline (PBS), then cultured in PBS (1 worm/1 ml PBS) at 37 °C for 60 min to remove host contaminants (e.g., bile, liver tissue and blood) from the guts. The parasites were then incubated in RPMI 1640 culture medium (GIBCO, Grand Island, NY, USA) containing 0.1% glucose, 100 U penicillin and 100 μg/ml streptomycin (Solarbio, Beijing, China), at 1 worm/ml culture medium for 5 h at 37 °C. The supernatant was collected and used for the next step.

EV isolation and purification

Extracellular vesicles were isolated from F. gigantica culture media according to the differential centrifugation protocol reported by Marcilla et al. [22] with some modifications. Briefly, the parasite culture media was centrifuged at 300 g for 15 min and then at 700 g for 30 min to remove eggs, cells and large cell debris. The supernatant was then centrifuged at 2000 g for 45 min at 4 °C, and the resulting supernatant was centrifuged at 15,000 g for 60 min at 4 °C to obtain 15k EVs (mainly microvesicles). ESP supernatants were then filtered through a 0.22-μm ultrafiltration membrane and the filtered supernatants centrifuged at 100,000 g for 90 min at 4 °C to pellet the 100k EVs (exosome-like EVs). Both the 15k and 100k EV pellets were washed twice with a large volume of PBS at the same high speed. The resulting supernatant was concentrated using Amicon® Ultra-15 3 kDa molecular weight cut-off (NMWCO) tubes (MilliporeSigma, Burlington, MA, USA) at 5000 g for 4 °C and then washed 3 times with PBS. Protein concentrations of ESP supernatants (depleted of EVs) consist of filtered samples and the 3k permeate. Protein contents were quantified by the bicinchoninic acid assay (BCA) kit (CWBIO, Beijing, China) and then stored at − 80 °C for further studies.

Transmission electron microscopy analysis of EV samples

The 15k pelleted EVs and 100k pelleted EVs were positioned on formvar-coated copper grids (Zhongjingkeyi Technology, Beijing, China) and stained with 2% phosphotungstic acid (Solarbi) for 1 min and at room temperature. EVs on the grids were imaged using a Hitachi-H7700 transmission microscope (Hitachi, Tokyo, Japan) and exposed at 100 kV.

Nanoparticle tracking analysis

To measure the size distribution of particles in the EV samples, nanoparticle tracking analysis (NTA) was carried out using the Zetasizer Nano ZSP high performance particle characterization system (Malvern Instruments, Malvern, UK) to capture and analyze the data. EVs were diluted in PBS and then loaded into the sample chamber. For each sample, three measurements were performed and the data were analyzed.

Proteomic analysis of F. gigantica 100k EVs

Proteomic analysis was done on F. gigantica 100k EVs, and two samples that had been independently separated were assayed. The 100k EV protein samples were digested with trypsin as described by Wu and Liu [23], with some modifications. Briefly, approximately 60 μg of the 100k EV sample was first reduced with 100 mM dithiothreitol (DTT) and then incubated in a boiling water bath for 5 min, following which 200 μl of UA buffer (8 M urea, 150 mM Tris–HCl, pH 8.0) was added and the solution mixed. The mixture was transferred to an ultrafiltration device (10 kDa) for centrifugation, and the supernatant was removed. Then 100 μl iodoacetamine (IAA) buffer (100 mM IAA in UA buffer) was added to the sample pellet and the mixture shocked for 1 min. The samples were incubated for 30 min in darkness at room temperature, following which 100 μl of UA buffer was added and centrifuged; this procedure was repeated twice. Then 100 μl of 25 mM of NH4HCO3 was added and the mixture centrifuged; this procedure was repeated twice. The proteins were then incubated with 5 μg of trypsin in 40 μl of 100 mM NH4HCO3 at 37 °C for 18 h, followed by centrifugation. Finally, 40 μl of 25 mM of NH4HCO3 was added, and the mixture was centrifuged and acidified. The digestion products were collected for subsequent analysis. According to the quantitative results, 3 µg of the digested peptides was analyzed by LC–MS/MS (Thermo Fisher Scientific, Waltham, MA, USA). Digested peptides pre-equilibrated with buffer A (0.1% v/v formic acid aqueous solution) were added to a 5-μm C18 EASY column (2 × 100 μm; Thermo Fisher Scientific) and separated with a linear gradient of buffer B (0.1% v/v formic acid in 84% v/v acetonitrile aqueous solution) on a 3 μm-C18 EASY column (75 μm × 100 mm 3-μm C18 column; Thermo Fisher Scientific). The Easy nLC system (Thermo Fisher Scientific) was used to deliver buffer A and buffer B with a linear gradient of 0–55% (0–110 min), 55–100% (110–115 min) and maintained at 100% (115–120 min), at a flow rate of 300 nl/min. The MS scan data were acquired using the Q-Exactive spectrometer (Thermo Fisher Scientific), and the 20 most abundant precursor ions from the survey scan (300–1800 m/z) were selected for higher-energy collisional dissociation fragmentation. The automatic gain control (AGC) target was set to 3e6, maximum inject time (IT) was 50 ms and dynamic exclusion duration was 60.0 s. Using predictive automatic gain control, scans were acquired at a resolution of 70,000 at m/z 200 with a dynamic exclusion duration of 60 s, and the target value was determined for full scans. The resolution for the high-energy collisional dissociation spectra was set to 17,500 at m/z 200, with an isolation window at 2 m/z. The normalized collision energy was set at 27 eV, and the underfill ratio was defined as 0.1%.

The FASTA database was from F. hepatica (consisting of 26,283 entries, downloaded on 10 Jan 2020) and from F. gigantica (consisting of 13,094 entries) obtained from UniProt (https://www.uniprot.org/) were used for the analysis of the EV mass spectrometry data through Proteome Discoverer 2.2 (Thermo Fisher Scientific). Only proteins with at least three peptides were considered to be positively identified.

Protein expression and purification of recombinant F. gigantica heat shock protein 70

The full-length sequence of heat shock protein 70 (HSP70) (GenBank: ABS52703.1) of F. gigantica was obtained from the GenBank database. To produce HSP70, the F. gigantica HSP70 gene sequence was first synthesized; following codon optimization, the gene sequence cloned into a pET28a ( +) vector using BamHI and XhoI cloning sites. The expression pET28a(+) vector was transformed into Escherichia coli BL21 (DE3) competent cells and induced with 0.1 mM isopropylthio-β-galactoside (IPTG) (Solarbio) at 30 °C for 8 h. Recombinant F. gigantica HSP70 (rFg-HSP70) was purified by affinity chromatography using a His-tag Protein Purification Kit (Beyotime, Haimen, Jiangsu, China). New Zealand White rabbits were immunized with rFg-HSP70 to produce polyclonal antibodies against rFg-HSP70, using the method described by Anuracpreeda et al. [24].

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blot analysis

The 15k and 100k EVs (in 20-ug samples) were loaded onto a 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel for separation. The protein products were transferred to 0.45-μm polyvinylidene difluoride membranes (MilliporeSigma). The membranes were blocked with blocking solution (PBST: PBS, 0.05% Tween-20, 5% non-fat powdered milk) for 4 h at room temperature, followed by overnight incubation at 4 °C with rabbit anti-human CD63 monoclonal antibody (dilution 1:500; Abcam, Cambridge, UK) and rabbit polyclonal antibodies raised against F. gigantica leucine amino peptidase (LAP), HSP70 and 14-3-3 epsilon (dilution 1:200). Antibodies were prepared previously in our laboratory [25]. The membranes were then washed 5 times for 10 min each time with PBST, followed by incubation for 4 h at 4 °C with the secondary goat anti-mouse immunoglobulin G (IgG; (dilution 1:5000; Abcam) antibody conjugated with horseradish peroxidase (HRP). After five washes of 10 min each with PBST for chemiluminescence imaging with a BeyoECL Plus kit (Beyotime), the membranes were visualized using the ImageQuant LAS 500 imager (Cytiva, Marlborough, MA, USA).

Vaccination studies on experimental animals and vaccination protocol

Forty 7-week-old female ICR mice were randomly divided into five groups (8 mice/group): (i) a non-immunized and uninfected group (Blank group); (ii) an infected group immunized with PBS + alum adjuvant (Thermo Fisher Scientific, Rockford, IL, USA) (Alum + PBS group); (iii) an infected group immunized with 200 μg of ESP (depleted of EVs) + alum adjuvant (Alum + ESP group); (4) an infected group immunized with 200 μg of 15k EVs + alum adjuvant (Alum + 15k EVs group); (v) an infected group immunized with 200 μg of 100k EVs + alum adjuvant (Alum + 100k EVs group); and (vi) an infected group immunized with 200 μg of rFg-HSP70 + alum adjuvant (Alum + rHSP70 group). Mice were maintained in the laboratory animal room of Parasitology Unit, Guangxi University, China. All animal experimental procedures were performed according to the National Institutes of Health guide for the care and use of laboratory animals (NIH Publication No. 8023, revised 1978). Mice were kept in steel cages in an air-conditioned room at 23 ± 2 °C, under a 12:12-h (L/D) photoperiod and 50–60% relative humidity. Vaccines were injected intraperitoneally on days 0, 14 and 28. Treated mice were challenged with 15 F. gigantica metacercariae via the oral route of administration, on day 42. At 28 day post-challenge, mice were sacrificed using CO2, and blood samples were collected for serum by heart puncture. The peritoneal cavities were opened and washed with PBS. Whole livers were collected to determine the number of F. gigantica flukes (Fig. 4).

Worm recovery and percentage protection

The percentage reduction of F. gigantica worm recovery was calculated as previously described [26]. Worm reduction (%) = (A − B)/A) × 100%, where A = worm burden immunized with PBS + alum adjuvant group and B = worm burden in the challenged immunized group.

Antiparasite IgG1 and IgG2a/c ELISAs

Specific IgG, IgG1 and IgG2a against F. gigantica 15k EVs, F. gigantica 100k EVs or F. gigantica ESPs were carried out by indirect enzyme-linked immunosorbent assay (ELISA) as described previously [3]. The serum IgG, IgG1, and IgG2a antibody response against F. gigantica 15k EVs, 100k EVs and ESPs was measured, in triplicate, for each group by indirect ELISA.

Statistical analyses

Results are presented as the means ± standard error of the mean (SEM), and analyses were performed using GraphPad Prism software version 6.01 (GraphPad Software Inc., San Diego, CA, USA). Statistical analysis was evaluated by one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test or Student’s t-test. P < 0.05 indicated statistical significance (*P < 0.05, **P < 0.01, ***P < 0.001).

Results

Characterization of 15k EVs and 100k EVs isolated from F. gigantica ESPs

We used the BCA kit to determine the relative contributions of the 15k EVs, 100k EVs and ESP supernatant to the total amount of protein secreted by adult F. gigantica. We found that F. gigantica secreted total protein at a rate of 64.3 μg/fluke/h (100%). A secretion rate of 2.85 μg/fluke/h (4.4%) was associated with the 15k EVs and a secretion rate of 1.3 μg/fluke/h (2.0%) was associated with the 100k EVs; however, the majority of soluble proteins (> 90%) remained in the ESP. The results from the transmission electron microscopy (TEM) and NTA studies confirmed that we had successfully isolated two different types of EVs from the F. gigantica culture media. Pellets from the 15,000 g centrifugation ranged from 91.28 nm to 825 nm in diameter, with most vesicles (> 74%) larger than 200 nm (Fig. 1c) and with typical characteristics of microvesicles (Fig. 1a). Pellets from the 100,000 g centrifugation were composed of vesicles ranging in diameter from 43.82 to396.1 nm, with most vesicles (> 86%) being < 200 nm in diameter (Fig. 1c) and with cup-shaped structures (Fig. 1b).

Fig. 1
figure 1

Identification of different Fasciola gigantica extracellular vesicles (EVs). a, b Morphological characterization by TEM by TEM of 15k EVs and 100k EVs released by adult F. gigantica. Arrowheads indicate EVs stained with 2% phosphotungstic acid. c Diameter distribution of the purified 15k EVs and 100k EVs from adult F. gigantica. The results represent data from three independent F. gigantica 15k EV and 100k EV preparations analyzed by the Zetasizer Nano ZSP high performance particle characterization system. d Western blot analysis of F. gigantica 15k EVs and 100k EVs using antibodies against F. gigantica leucine amino peptidase (LAP), heat shock protein 70 (HSP70), 14-3-3epsilon (14-3-3e), enolase and human CD63. TEM, Transmission electron microscopy

Full size image

Proteomic analysis of F. gigantica-derived 100k EVs

A total of 705 proteins were identified (≥ 3 matched unique peptides) from F. gigantica-derived 100k EVs (Additional file 1: Table S1). Among the identified proteins, the most abundant proteins were dynein heavy chain 1 cytosolic, otoferlin, myoferlin, programmed cell death 6-interacting protein, vacuolar protein-sorting-associated protein 4, receptor mediated endocytosis, serine/threonine-protein kinase PAK and leucine amino peptidase (Table 1). Many proteins that have been observed in exosomes, such as exosome biogenesis or vesicle trafficking proteins (annexin, tetraspanin family members, acid sphingomyelinase, myoferlin, otoferlin, charged multivesicular body protein, Rab family members, vacuolar protein sorting 26, syntenin), endosomal sorting complex required for transport (ESCRT; including ESCRT-II complex subunit, charged multivesicular body proteins, protein IST1, syntenin), heat shock proteins and 14-3-3 [11, 27], were identified in F. gigantica-derived 100k EVs (Additional file 1: Table S1). Among these proteins, HSP70, CD63, 14-3-3, annexin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which are typically found in helminth exosomes like EVs, were identified (Fig. 1d; Table 1). The identification of these proteins indicates the successful isolation of exosome-like vesicles from adult F. gigantica culture supernatants. Several proteins identified in the 100k EVs have already been characterized as possible vaccine candidates against fascioliasis, including cathepsin L [28], leucine aminopeptidase [29], 14-3-3 [30], fatty acid binding protein (FABP) [31], phosphoglycerate kinase [32], cathepsin B [33], and tetraspanin 2 (-TSP2) [34], but with different protective efficacies.

Table 1 Top 50 proteins identified by mass spectrometry from 100k extracellular vesicles isolated from adult Fasciola gigantica culture supernatants
Full size table

Following a gene ontology (GO) analysis, the most represented GO terms in the category biological processes in the F. gigantica 100k EV proteins were assigned as “proteolysis involved in cellular protein catabolic process,” “cellular protein catabolic process” and “organonitrogen compound catabolic process” (Fig. 2a). Similarly, the most represented GO terms within the category molecular function were “guanyl ribonucleotide binding,” “purine nucleoside binding,” “purine ribonucleoside binding” and “GTP binding” (Fig. 2b). The “proteasome core complex,” “cytoplasm,” “proteasome core complex,” “alpha-subunit complex” and “extracellular space” terms were classified within the category “cellular component” (Fig. 2c).

Fig. 2
figure 2

Gene ontology (GO) of protein cargo enriched in F. gigantica-derived 100k EVs. a GO biological process terms of adult F. gigantica-derived 100k EVs, b GO molecular function terms of adult F. gigantica-derived 100k EVs, c GO cellular component terms of adult F. gigantica-derived 100k EVs. The size and color of the circle represent the number of genes and the P-value

Full size image

Worm recoveries and percentages of protection

Proteomic data indicated that many of the proteins present in the F. gigantica-secreted 100k EVs are known vaccine candidates. We tested whether immunization with F. gigantica ESPs (depleted of EVs), 15k EVs, 100k EVs and rFg-HSP70 (Fig. 3) could induce protective immunity in vivo. Following vaccination and subsequent F. gigantica metacercariae challenge, gross liver lesions appeared which were similar in all infected mice. These lesions were characterized by fibrosis spots, tortuous whitish tracts and patches and thickened and calcified deposits on the surface (Fig. 4). Representative liver lesion area reduction was observed in mice after vacination with ESPs, 15k EVs, 100k EVs and rFg-HSP70 vaccination (Fig. 4). The mice immunized with 100k EVs, 15k EVs and ESPs also showed a marked reduction in fluke burden compared with adjuvant control groups. The percentages of protection were 37.73% (one-way ANOVA, F(4, 35) = 7.345, P = 0.0402) for F. gigantica 100k EVs, 60.38% (one-way ANOVA, F(4, 35) = 7.345, P = 0.0006) for F. gigantica 15k EVs, 67.90% (one-way ANOVA, F(4, 35) = 7.345, P = 0.0001) for F. gigantica ESPs and 56.6% for rFg-HSP 70 (one-way ANOVA, F(4, 35) = 7.345, P = 0.0013) (Fig. 5).

Fig. 3
figure 3

Expression and purification of recombinant F. gigantica heat shock protein 70 (rFg-HSP70). Lanes: M, protein marker; 1, supernatant expression products of pET-28a induced by isopropylthio-β-galactoside (IPTG); 2, inclusion body of pET-28a induced by IPTG expression products; 3, supernatant expression products of pET-28a-FgHSP70 induced by IPTG; 4, 5, purification of rFg-HSP70 (arrow)

Full size image
Fig. 4
figure 4

EVs stimulate protective immunity against F. gigantica metacercariae challenge in ICR mice. Female ICR mice, n = 8 per group, were vaccinated (intraperitoneally [I.P.]) with 15k EVs, 100k EVs, ESPs, rFg-HSP70 or PBS in alum adjuvant prior to challenge with 15 F. gigantica metacercariae. Shown are representative pictures of macroscopic pathological lesions in livers of infected mice recovered at 4 weeks post-infection. Groups: Alum:ESP, ESP-immunized and infected group; Alum:15k EVs, 15k EV-immunized and infected group; Alum:100k EVs, 100k EV-immunized and infected group; Alum:HSP70, rFg-HSP70-immunized and infected group; Alum:PBS, adjuvant-infected control group; Blank, non-immunized and non-infected group. ESPs, Excretory/secretory products

Full size image
Fig. 5
figure 5

Fluke burden from each ICR mouse was recorded at 28 days post-infection (n = 8). Asterisks indicate level of significance between groups: *P < 0.05, **P< 0.01, ***P < 0.001. NS, Non-significant

Full size image

Antibody levels

Anti-parasite-specific IgG1 and IgG2a serum antibodies are often used as reference indexes of resistance or chronicity during F. gigantica infection [26, 33]. ICR mice vaccinated with 15k EVs, 100k EVs and ESP showed a significant increase in sera-specific IgG (Fig. 6a–c), IgG1 (Fig. 6d–f) and IgG2 (Fig. 6g–i) levels compared with the adjuvant control group and the blank group. Mice immunized with 100k EVs produced distinct levels of 15k EVs and ESP-responsive IgG, IgG1 and IgG2. Similarly, sera from mice vaccinated with 15k EVs or F. gigantica ESPs contained both IgG, IgG1 and IgG2 reactive to F. gigantica 15k EVs, F. gigantica 100k EVs and F. gigantica ESPs, indicating that they may share homologous protein components. However, there was no significant difference in specific IgG2a between the adjuvant control group and the uninfected group. IgG2a can represent the Th1-type immune response to a certain extent, and induction of the Th1-type immune response and a high level of IgG2a is key to vaccine protection.

Fig. 6
figure 6

Serum IgG, IgG1, IgG2a levels in vaccinated ICR mouse. Serum IgG (a–c), IgG1(d–f) and IgG2a (g–i) levels were measured from the vaccinated groups (mice immunized with 15k EVs, 100k EVs, ESPs and PBS in alum adjuvant prior to challenge with 15 F. gigantica metacercariae) and non-immunized and uninfected group. Mean IgG (a–c), IgG1 (d–f) and IgG2a (g–i) levels were measured against ESPs (a, d, g), 15k EVs (b, e, h) and 100k EVs (c, f, i) by indirect enzyme-linked immunosorbent assay. Results represent the mean absorbance measured at 450 nm for each group. Asterisks indicate level of significance between groups: *P < 0.05, **P < 0.01, ***P < 0.001. NS, Non-significant

Full size image

Discussion

The TEM analysis and nanoparticle tracking analysis indicated the successful isolation of two subpopulations of EVs from adult F. gigantica culture supernatants using differential centrifugation. Of these, 15k EVs ranged from 91.28 to 825 nm in diameter, and the majority (> 200 nm) had characteristics typical of microvesicles [35], and the 100k EVs ranged from 43.82 to 396.1 nm in diameter and were mainly < 200 nm in diameter, with typical cup-shaped structures. These characteristics are similar to those recorded in our previous studies F. gigantica 110k EVs [36] and previously reported 120k exosome-like vesicles isolated from F. hepatica [37]. The size and characteristics of the 100k EVs are comparable to exosome-like vesicles isolated from other trematodes, nematodes and cestodes. The dimensions of exosome-like vesicles obtained from F. hepatica ranged from 37 to 153 nm [37]. In Schistosoma mansoni, the comparable values were 50–130 nm [38]; in O. viverrini, 40–180 nm [15]; in Nippostrongylus brasiliensis, 60–160 nm [39]; in Trichuris muris 30–150 nm [40]; in Brugia malayi, 85–200 nm [41]; in Ascaris suum, 80–200 nm [42] and in E. granulosus, 50– 350 nm [43]. NTA analysis showed that F. hepatica 120k EVs and F. gigantica 110k EVs are smaller than the 100k EVs [11]. We suggest that centrifugation at 100,000 g may result in the loss of some small exosome-like EVs. Exosome biogenesis or vesicle trafficking proteins, ESCRT pathway proteins as well as exosome markers, heat shock proteins and 14-3-3 were identified in 100k EVs during the proteomics analysis. These results indicate successful isolation of exosome-like vesicles from adult F. gigantica culture supernatants.

We identified several proteases, such as legumain, cathepsin Bs, cathepsin Ls, proteasome subunit alpha, proteasome subunit beta, proteasome subunit alpha type, aminopeptidase, serpin and cystatin. Proteases produced by helminths are essential for successful tissue invasion during migration [44, 45], the degradation of hemoglobin for food processing, the degradation of IgG for preventing the antibody-dependent cell cytotoxicity response (ADCC) [46], the degradation of immune cell surface receptors [47] and intracellular signaling [48] for immune modulators. We also identified glycolytic enzymes in 100k EVs, including triose phosphate isomerase, GAPDH, phosphoglycerate kinase, phosphoglycerate mutase and glucose-6-phosphate isomerase. Glycolytic enzymes are involved in generating ATP and NADH, which enable helminths to obtain energy [49]. In addition to their role in glycolysis, glycolytic enzymes may function in a variety of other biological functions, such as immune invasion, virulence and immunoregulation [50]. Veamurthy et al. [51] found that GAPDH secreted by Haemonchus contortus could bind to complement C3, which may inhibit complement activation and membrane attack complex formation, thus causing immune suppression. GAPDH expressed on the surface of Plasmodium sporozoite binds to the CD68 receptor on the surface of Kupffer cells, promoting sporozoite liver invasion [52]. These observations indicate that glycolytic enzymes in 100k EVs are possible vaccine candidates against fascioliasis. The GAPDH of O. volvulus [53], S. mansoni [54] and E. multilocularis [55] have been evaluated as vaccines with high efficacies.

In F. gigantica 100k EVs, some proteins that can bind to F. gigantica-positive serum from infected buffaloes were also found, including tubulin alpha, glucose transporter-2 protein, glutathione S-transferase, phosphoglycerate kinase, cathepsin B5, cathepsin L, calcium-binding protein, HSP70, kunitz, 14-3-3 protein, leucine amino peptidase, multidomain cystatin, secreted saposin-like protein SAP-3 and thioredoxin [56]. Liu et al. [57] found that F. hepatica ESPs could bind with Th1-related cytokines (IL-2 and interferon gamma [IFN-γ]) and Th17-related cytokine (IL-17). We also identified these proteins in our proteome analysis. Proteins such as annexin, phosphoenolpyruvate carboxykinase and fructose-bisphosphate aldolase bind to IL-2; phosphatidylinositol-4,5-bisphosphate 4-phosphatase and fructose-bisphosphate aldolase bind to IFN-γ; and glutathione S-transferase, severin, annexin, Sh3-containing grb2 protein 1 and malic enzyme bind to IL-17. Such binding suggests that these proteins bind to the host pro-inflammatory cytokines and deactivate these cytokines. This is also an important part of parasite immune evasion. These data suggest that these proteins may be potential diagnostic markers or vaccine candidates.

HSP70 is an EV-rich fraction, and we found a large amount of HSP70 in the proteomic data. HSP70 is a highly conserved molecular chaperone that plays an essential role in homeostasis during host invasion and helps parasites adapt to rapidly changing environments [58, 59]. HSP70 from helminths are considered to be promising vaccine candidates [60, 61]. HS70 can also be used as adjuvant antigenic conjugate to induce specific antigen-specific immunity [62, 63]. However, the extent to which F. gigantica HSP70 can induce a protective immunity response remains unclear. Reduction in the fluke burden is a key parameter for evaluating vaccine efficacy after a challenge with F. gigantica metacercariae. In this study, we demonstrated that vaccination with F. gigantica 100k EVs, 15k EVs, ESPs (depleted of EVs) and rFg-HSP70 can induce protective immunity against a subsequent F. gigantica infection. Mice immunized with ESPs, 15k EVs, 100k EVs and rFg-HSP70 showed significant reductions (P < 0.05) in fluke burden, which induced a significant level of protection of 67.9%, 60.4%, 37.7%, and 56.6%, respectively. Fasciola gigantica ESPs, 15k EVs and 100k EVs induce high levels of the antigen-specific IgG, IgG1, and IgG2a antibodies in mice. It is possible that common proteins may be shared among F. gigantica 100k EVs, 15k EVs and ESPs. Similar results were found in studies of F. hepatica [11], H. polygyrus [21] and Echinostoma caproni [64], demonstrating that overlapping proteins were present in EVs and ESPs isolated from these helminths. Antigen-specific responsive IgG2a antibody could also be important for downstream resistance during F. gigantica infection. Higher IgG2a antibody responses have been associated with lower fluke burdens in Fasciola spp. vaccine research [33, 65, 66], suggesting that the Th1 response may be associated with protection against fascioliasis.

Conclusion

We purified and characterized the proteomic composition of exosome-like vesicles from F. gigantica culture media. Fasciola gigantica exosome-like vesicles containing proteins may be related to immunomodulatory, immune evasion and virulence. Vaccination with F. gigantica exosome-like vesicles protected mice against subsequent infection by F. gigantica metacercariae. Our results may provide good insights into novel strategies for the immunotherapy, vaccination, and diagnosis of fascioliasis.

Availability of data and materials

The datasets supporting the findings of this article are included within the paper and its supplementary materials.

Abbreviations

ADCC:

Antibody-dependent cell cytotoxicity response

DCs:

Dendritic cells

DTT:

Dithiothreitol

ELISA:

Enzyme linked immunosorbent assay

ESPs:

Excretory/secretory products

EVs:

Extracellular vesicles

GAPDH:

Glyceraldehyde-3-phosphate dehydrogenase

GO:

Gene ontology

HSP70:

Heat shock protein 70

IFN-γ:

Interferon gamma

IL-2:

Interleukin 2

IL-17:

Interleukin 17

IPTG:

Isopropylthio-β-galactoside

LC–MS/MS:

Liquid chromatographytandem mass spectrometry

NTA:

Nanoparticle tracking analysis

PBS:

Phosphate-buffered saline

SDS-PAGE:

Sodium dodecyl sulfate polyacrylamide gel electrophoresis

TEM:

Transmission electron microscopy

References

  1. Yadav SC, Sharma RL, Kalicharan A, Mehra UR, Verma AK. Primary experimental infection of riverine buffaloes with Fasciola gigantica. Vet Parasitol. 1999;82:285–96.

    Article  CAS  PubMed  Google Scholar 

  2. Mehmood K, Hui Z, Sabir AJ, Abbas RZ, Ijaz M, Durrani AZ, et al. A review on epidemiology, global prevalence and economical losses of fasciolosis in ruminants. Microb Pathog. 2017;109:253–62.

    Article  PubMed  Google Scholar 

  3. Sheng ZA, Li J, Wang DY, Kang YQ, Wei ZY, Zhang FK, et al. Th2-related cytokines are associated with Fasciola gigantica infection and evasion in the natural host, swamp buffalo. Vet Parasitol. 2019;268:73–80.

    Article  CAS  PubMed  Google Scholar 

  4. Zhang WY, Moreau E, Hope JC, Howard CJ, Huang WY, Chauvin A. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep. Exp Parasitol. 2005;111:154–9.

    Article  CAS  PubMed  Google Scholar 

  5. Mei XF, Shi W, Zhang YY, Zhu B, Wang YR, Hou LJ, et al. DNA methylation and hydroxymethylation profiles reveal possible role of highly methylated TLR signaling on Fasciola gigantica excretory/secretory products (FgESPs) modulation of buffalo dendritic cells. Parasit Vectors. 2019;12:358.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mei X, Shi W, Zhao W, Luo H, Huang W. Fasciola gigantica excretory-secretory products (FgESPs) modulate the differentiation and immune functions of buffalo dendritic cells through a mechanism involving DNMT1 and TET1. Parasit Vectors. 2020;13:355.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Luo HL, Zhang YY, Sheng ZA, Luo T, Chen J, Liu JJ, et al. Long noncoding RNA profiling from Fasciola Gigantica excretory/secretory product-induced M2 to M1 macrophage polarization. Cell Physiol Biochem. 2018;47:505–22.

    Article  CAS  PubMed  Google Scholar 

  8. Nutman TB. Looking beyond the induction of Th2 responses to explain immunomodulation by helminths. Parasite Immunol. 2015;37:304–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wu Z, Wang L, Li J, Wang L, Wu Z, Sun X. Extracellular vesicle-mediated communication within host-parasite interactions. Front Immunol. 2019;9:3066.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bennett A, Torre-Escudero E, Oliver N, Huson KM, Robinson MW. The cellular and molecular origins of extracellular vesicles released by the helminth pathogen, Fasciola hepatica. Int J Parasitol. 2020;50:671–83.

    Article  CAS  PubMed  Google Scholar 

  11. Cwiklinski K, De L, Trelis M, Bernal D, Dufresne P, Brennan G, et al. The extracellular vesicles of the helminth pathogen, Fasciola hepatica: biogenesis pathways and cargo molecules involved in parasite pathogenesis. Mol Cell Proteomics. 2015;14:3258–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Andaloussi SE, Mager I, Breakefield XO, Wood M. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347–57.

    Article  PubMed  Google Scholar 

  13. Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. de la Torre-Escudero E, Gerlach JQ, Bennett APS, Cwiklinski K, Jewhurst HL, Huson KM, et al. Surface molecules of extracellular vesicles secreted by the helminth pathogen Fasciola hepatica direct their internalisation by host cells. PLoS Negl Trop Dis. 2019;13:e7087.

    Google Scholar 

  15. Chaiyadet S, Sotillo J, Smout M, Cantacessi C, Loukas A. Carcinogenic liver fluke secretes extracellular vesicles that promote cholangiocytes to adopt a tumorigenic phenotype. J Infect Dis. 2015;212:1636–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Buck AH, Coakley G, Simbari F, McSorley HJ, Quintana JF, Le Bihan T, et al. Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun. 2014;5:5488.

    Article  CAS  PubMed  Google Scholar 

  17. Liu J, Zhu L, Wang J, Qiu L, Chen Y, Davis RE, et al. Schistosoma japonicum extracellular vesicle miRNA cargo regulates host macrophage functions facilitating parasitism. PLoS Pathog. 2019;15:e1007817.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zheng Y, Guo X, Meng S, Guo A, Luo X. Regulatory effects of Echinococcus multilocularis extracellular vesicles on RAW264.7 macrophages. Vet Parasitol. 2017;235:29–36.

    Article  CAS  PubMed  Google Scholar 

  19. Nicolao MC, Rodriguez Rodrigues C, Cumino AC, Siles-Lucas M. Extracellular vesicles from Echinococcus granulosus larval stage: Isolation, characterization and uptake by dendritic cells. PLoS Negl Trop Dis. 2019;13:e0007032.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Marcilla A, Martin-Jaular L, Trelis M, de Menezes-Neto A, Osuna A, Bernal D, et al. Extracellular vesicles in parasitic diseases. J Extracell Vesicles. 2014;3:25040.

    Article  PubMed  Google Scholar 

  21. Coakley G, Mccaskill JL, Borger JG, Simbari F, Robertson E, Millar M, et al. Extracellular vesicles from a helminth parasite suppress macrophage activation and constitute an effective vaccine for protective immunity. Cell Rep. 2017;19:1545–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Marcilla A, Trelis M, Cortes A, Sotillo J, Cantalapiedra F, Minguez MT, et al. Extracellular vesicles from parasitic helminths contain specific excretory/secretory proteins and are internalized in intestinal host cells. PLoS ONE. 2012;7:e45974.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wu CX, Liu ZF. Proteomic profiling of sweat exosome suggests its involvement in skin immunity. J Invest Dermatol. 2017;138:89–97.

    Article  PubMed  Google Scholar 

  24. Anuracpreeda P, Chawengkirttikul R, Sobhon P. Immunodiagnosis of Fasciola gigantica infection using monoclonal antibody-based sandwich ELISA and immunochromatographic assay for detection of circulating cathepsin L1 protease. PLoS ONE. 2016;11:e145650.

    Article  Google Scholar 

  25. Tian A, Lu M, Calderón-Mantilla G, Petsalaki E, Dottorini T, Tian X, et al. A recombinant Fasciola gigantica 14-3-3 epsilon protein (rFg14-3-3e) modulates various functions of goat peripheral blood mononuclear cells. Parasit Vectors. 2018;11:152.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Changklungmoa N, Phoinok N, Yencham C, Sobhon P, Kueakhai P. Vaccine potential of recombinant cathepsinL1G against Fasciola gigantica in mice. Vet Parasitol. 2016;226:124–31.

    Article  CAS  PubMed  Google Scholar 

  27. Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell. 2019;177:428–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Villa-Mancera A, Alcalá-Canto Y, Olivares-Pérez J, Molina-Mendoza P, Reynoso-Palomar A. Vaccination with cathepsin L mimotopes of Fasciola hepatica in goats reduces worm burden, morphometric measurements, and reproductive structures. Microb Pathog. 2021;155:104859.

    Article  CAS  PubMed  Google Scholar 

  29. Salazar C, Tort JF, Carmona C. Design of a peptide-carrier vaccine based on the highly immunogenic Fasciola hepatica leucine aminopeptidase. Methods Mol Biol. 2020;2137:191–204.

    Article  CAS  PubMed  Google Scholar 

  30. Perez-Caballero R, Siles-Lucas M, Gonzalez-Miguel J, Martinez-Moreno FJ, Escamilla A, Perez J, et al. Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica. Vet Immunol Immunopathol. 2018;202:115–21.

    Article  CAS  PubMed  Google Scholar 

  31. Vicente B, Lopez-Aban J, Rojas-Caraballo J, Del OE, Fernandez-Soto P, Muro A. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems. Parasit Vectors. 2016;9:216.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wesolowska A, Zawistowska-Deniziak A, Norbury LJ, Wilkowski P, Januszkiewicz K, Pyziel AM, et al. Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection. Acta Parasitol. 2016;61:212–20.

    Article  CAS  PubMed  Google Scholar 

  33. Chantree P, Phatsara M, Meemon K, Chaichanasak P, Changklungmoa N, Kueakhai P, et al. Vaccine potential of recombinant cathepsin B against Fasciola gigantica. Exp Parasitol. 2013;135:102–9.

    Article  CAS  PubMed  Google Scholar 

  34. Zerna G, Rathinasamy VA, Toet H, Anderson G, Dempster R, Spithill TW, et al. Evaluation of immunogenicity and efficacy of Fasciola hepatica tetraspanin 2 (TSP2) Fused to E. coli heat-labile enterotoxin B subunit LTB adjuvant following intranasal vaccination of cattle. Vaccines. 2021;9:1213.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Crescitelli R, Lasser C, Szabo TG, Kittel A, Eldh M, Dianzani I, et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles. 2013;2:20677.

    Article  Google Scholar 

  36. Guo A, Wang L, Meng X, Zhang S, Sheng Z, Luo X, et al. Extracellular vesicles from Fasciola gigantica induce cellular response to stress of host cells. Exp Parasitol. 2021;231:108173.

    Article  CAS  PubMed  Google Scholar 

  37. Davis CN, Phillips H, Tomes JJ, Swain MT, Wilkinson TJ, Brophy PM, et al. The importance of extracellular vesicle purification for downstream analysis: a comparison of differential centrifugation and size exclusion chromatography for helminth pathogens. PLoS Negl Trop Dis. 2019;13:e0007191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Sotillo J, Pearson M, Potriquet J, Becker L, Pickering D, Mulvenna J, et al. Extracellular vesicles secreted by Schistosoma mansoni contain protein vaccine candidates. Int J Parasitol. 2016;46:1–5.

    Article  CAS  PubMed  Google Scholar 

  39. Eichenberger RM, Stephanie R, Linda J, Geraldine B, Ramona P, Marcela MDO, et al. Hookworm secreted extracellular vesicles interact with host cells and prevent inducible colitis in mice. Front Immunol. 2018;9:850.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Eichenberger RM, Talukder MH, Field MA, Wangchuk P, Giacomin P, Loukas A, et al. Characterization of Trichuris muris secreted proteins and extracellular vesicles provides new insights into host-parasite communication. J Extracell Vesicles. 2018;7:1428004.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Harischandra H, Yuan W, Loghry HJ, Zamanian M, Kimber MJ. Profiling extracellular vesicle release by the filarial nematode Brugia malayi reveals sex-specific differences in cargo and a sensitivity to ivermectin. PLoS Negl Trop Dis. 2018;12:e0006438.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hansen EP, Fromm B, Andersen SD, Marcilla A, Andersen KL, Borup A, et al. Exploration of extracellular vesicles from Ascaris suum provides evidence of parasite-host cross talk. J Extracell Vesicles. 2019;8:1578116.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Yang J, Wu J, Fu Y, Yan L, Li Y, Guo X, et al. Identification of different extracellular vesicles in the hydatid fluid of Echinococcus granulosus and immunomodulatory effects of 110 K EVs on sheep PBMCs. Front Immunol. 2021;12:602717.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Hasnain SZ, McGuckin MA, Grencis RK, Thornton DJ. Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier. PLoS Negl Trop Dis. 2012;6:e1856.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Caffrey CR, Goupil L, Rebello KM, Dalton JP, Smith D. Cysteine proteases as digestive enzymes in parasitic helminths. PLoS Negl Trop Dis. 2018;12:e0005840.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Nishikado H, Fujimura T, Taka H, Mineki R, Ogawa H, Okumura K, et al. Cysteine protease antigens cleave CD123, the alpha subunit of murine IL-3 receptor, on basophils and suppress IL-3-mediated basophil expansion. Biochem Biophys Res Commun. 2015;460:261–6.

    Article  CAS  PubMed  Google Scholar 

  47. Sulaiman AA, Zolnierczyk K, Japa O, Owen JP, Maddison BC, Emes RD, et al. A trematode parasite derived growth factor binds and exerts influences on host immune functions via host cytokine receptor complexes. PLoS Pathog. 2016;12:e1005991.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Donnelly S, O’Neill SM, Stack CM, Robinson MW, Turnbull L, Whitchurch C, et al. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem. 2010;285:3383–92.

    Article  CAS  PubMed  Google Scholar 

  49. Gomez-Arreaza A, Acosta H, Quinones W, Concepcion JL, Michels PA, Avilan L. Extracellular functions of glycolytic enzymes of parasites: unpredicted use of ancient proteins. Mol Biochem Parasitol. 2014;193:75–81.

    Article  CAS  PubMed  Google Scholar 

  50. Sahoo S, Murugavel S, Devi IK, Vedamurthy GV, Gupta SC, Singh BP, et al. Glyceraldehyde-3-phosphate dehydrogenase of the parasitic nematode Haemonchus contortus binds to complement C3 and inhibits its activity. Parasite Immunol. 2013;35:457–67.

    Article  CAS  PubMed  Google Scholar 

  51. Vedamurthy GV, Sahoo S, Devi IK, Murugavel S, Joshi P. The N-terminal segment of glyceraldehyde-3-phosphate dehydrogenase of Haemonchus contortus interacts with complements C1q and C3. Parasite Immunol. 2015;37:568–78.

    Article  CAS  PubMed  Google Scholar 

  52. Cha SJ, Kim MS, Pandey A, Jacobs-Lorena M. Identification of GAPDH on the surface of Plasmodium sporozoites as a new candidate for targeting malaria liver invasion. J Exp Med. 2016;213:2099–112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Steisslinger V, Korten S, Brattig NW, Erttmann KD. DNA vaccine encoding the moonlighting protein Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (Ov-GAPDH) leads to partial protection in a mouse model of human filariasis. Vaccine. 2015;33:5861–7.

    Article  CAS  PubMed  Google Scholar 

  54. Argiro L, Henri S, Dessein H, Kouriba B, Dessein AJ, Bourgois A. Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorption with GM-CSF on alum. Vaccine. 2000;18:2033–8.

    Article  CAS  PubMed  Google Scholar 

  55. Muller-Schollenberger V, Beyer W, Schnitzler P, Merckelbach A, Roth S, Kalinna BH, et al. Immunisation with Salmonella typhimurium-delivered glyceraldehyde-3-phosphate dehydrogenase protects mice against challenge infection with Echinococcus multilocularis eggs. Int J Parasitol. 2001;31:1441–9.

    Article  CAS  PubMed  Google Scholar 

  56. Huang SY, Yue DM, Hou JL, Zhang XX, Zhang FK, Wang CR, et al. Proteomic analysis of Fasciola gigantica excretory and secretory products (FgESPs) interacting with buffalo serum of different infection periods by shotgun LC-MS/MS. Parasitol Res. 2019;118:453–60.

    Article  PubMed  Google Scholar 

  57. Liu Q, Huang SY, Yue DM, Wang JL, Wang Y, Li X, et al. Proteomic analysis of Fasciola hepatica excretory and secretory products (FhESPs) involved in interacting with host PBMCs and cytokines by shotgun LC-MS/MS. Parasitol Res. 2017;116:627–35.

    Article  PubMed  Google Scholar 

  58. Young RA, Elliott TJ. Stress proteins, infection, and immune surveillance. Cell. 1989;59:5–8.

    Article  CAS  PubMed  Google Scholar 

  59. Cwiklinski K, Jewhurst H, McVeigh P, Barbour T, Maule AG, Tort J, et al. Infection by the helminth parasite Fasciola hepatica requires rapid regulation of metabolic, virulence, and invasive factors to adjust to its mammalian host. Mol Cell Proteomics. 2018;17:792–809.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Fang L, Sun L, Yang J, Gu Y, Zhan B, Huang J, et al. Heat shock protein 70 from Trichinella spiralis induces protective immunity in BALB/c mice by activating dendritic cells. Vaccine. 2014;32:4412–9.

    Article  CAS  PubMed  Google Scholar 

  61. Zhang R, Sun Q, Chen Y, Sun X, Gu Y, Zhao Z, et al. Ts-Hsp70 induces protective immunity against Trichinella spiralis infection in mouse by activating dendritic cells through TLR2 and TLR4. PLoS Negl Trop Dis. 2018;12:e0006502.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Chung EJ, Jeong YI, Lee MR, Kim YJ, Lee SE, Cho SH, et al. Heat shock proteins 70 and 90 from Clonorchis sinensis induce Th1 response and stimulate antibody production. Parasit Vectors. 2017;10:118.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Duan MM, Xu RM, Yuan CX, Li YY, Liu Q, Cheng GF, et al. SjHSP70, a recombinant Schistosoma japonicum heat shock protein 70, is immunostimulatory and induces protective immunity against cercarial challenge in mice. Parasitol Res. 2015;114:3415–29.

    Article  PubMed  Google Scholar 

  64. Trelis M, Galiano A, Bolado A, Toledo R, Marcilla A, Bernal D. Subcutaneous injection of exosomes reduces symptom severity and mortality induced by Echinostoma caproni infection in BALB/c mice. Int J Parasitol. 2016;46:799–808.

    Article  CAS  PubMed  Google Scholar 

  65. Sangpairoj K, Apisawetakan S, Changklungmoa N, Kueakhai P, Chaichanasak P, Sobhon P, et al. Potential of recombinant 2-Cys peroxiredoxin protein as a vaccine for Fasciola gigantica infection. Exp Parasitol. 2018;194:16–23.

    Article  CAS  PubMed  Google Scholar 

  66. Jaikua W, Kueakhai P, Chaithirayanon K, Tanomrat R, Wongwairot S, Riengrojpitak S, et al. Cytosolic superoxide dismutase can provide protection against Fasciola gigantica. Acta Trop. 2016;162:75–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Prof. Xingquan Zhu for academic and technical assistance.

Funding

The work was supported by the National Natural Science Foundation of China (Grant No. 31760728), Guangxi Basic Scientific Research Project (No. 16-3), Guangxi Agricultural Science and Technology Project (Z202220), Lin He’s Academician Workstation of New Medicine and Clinical Translation in Jining Medical University (JYHL2019 ZD03, JYHL2021 MS22), Undergraduate Training Program for Innovation and Entrepreneurship of Jining Medical University (cx2021147) and Guangxi Key Research and Development Program (AB16380106).

Author information

Author notes

  1. Zhao-An Sheng, Cui-Lan Wu and Dong-Ying Wang contributed equally to this work

Authors and Affiliations

  1. Institute of Oncology, Guangxi Academy of Medical Sciences, Nanning, Guangxi, People’s Republic of China

    Hong-Lin Luo

  2. Guangxi Colleges and Universities Key Laboratory of Prevention and Control for Animal Disease, College of Animal Science and Technology, Guangxi University, Nanning, People’s Republic of China

    Zhao-An Sheng, Dong-Ying Wang, Xi Yang, Guo-Shun Rao, Wei-Yi Huang & Hong-Lin Luo

  3. Guangxi Key Laboratory of Veterinary Biotechnology, Guangxi Veterinary Research Institute, Nanning, Guangxi, People’s Republic of China

    Cui-Lan Wu, Shu-Hong Zhong, Hao Peng, Shi-Wen Feng & Jun Li

  4. Department of Pathogenic Biology, Jining Medical University, Shandong, People’s Republic of China

    Zhao-An Sheng

  5. Yuxi Animal Disease Prevention and Control Center, Yuxi, People’s Republic of China

    Xi Yang

  6. Key Laboratory of China (Guangxi)-ASEAN Cross-Border Animal Disease Prevention and Control, Ministry of Agriculture and Rural Affairs of China, Nanning, Guangxi, People’s Republic of China

    Cui-Lan Wu, Shu-Hong Zhong, Hao Peng, Shi-Wen Feng & Jun Li

Authors
  1. Zhao-An Sheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cui-Lan Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dong-Ying Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shu-Hong Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guo-Shun Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hao Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shi-Wen Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wei-Yi Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hong-Lin Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZAS, WYH and HLL conceived and designed the experiments. ZAS, CLW and DYW performed the majority of experiments. SHZ, XY, GSR, HP, SWF and JL contributed to the acquisition of data. ZAS, HLL, JL and WYH wrote the paper. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jun Li, Wei-Yi Huang or Hong-Lin Luo.

Ethics declarations

Ethics approval and consent to participate

All experimental animals were carried out in accordance with the Animal Ethics Procedures and Guidelines for the Use and Care of Laboratory Animals of the People’s Republic of China. All animal procedures were approved by the Ethics Committee of Guangxi University and Department of Science and Technology of Hunan province (Permit number:SYXK 2019-0017).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing financial interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

: Table S1. List of proteins identified by MS from EVs isolated from adult F. gigantica culture supernatants.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sheng, ZA., Wu, CL., Wang, DY. et al. Proteomic analysis of exosome-like vesicles from Fasciola gigantica adult worm provides support for new vaccine targets against fascioliasis. Parasites Vectors 16, 62 (2023). https://doi.org/10.1186/s13071-023-05659-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-023-05659-7

Keywords

Parasites & Vectors

ISSN: 1756-3305

Contact us